Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression

Clinical and Translational Oncology

Volumn 15, Issue 9, 2013, Pages 741-746

  Liu, P ^a   Liang, H ^b   Xia, Q ^c   Li, P ^a   Kong, H ^a   Lei, P ^a   Wang, S ^a   Tu, Z ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; BCL 2; miR 21; Pancreatic cancer; Resveratrol

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MICRORNA 21; PROTEIN BCL 2; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; PANCREAS CANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; STILBENES; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84883297845     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0999-4     Document Type: Article

References (22)

1. Kindler HL (2005) Front-line therapy of advanced pancreatic cancer. Semin Oncol 32:S33-S36
2. Harikumar KB, Aggarwal BB (2008) Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7:1020-1035
3. Borriello A, Cucciolla V, Della Raqione F, Galletti P (2010) Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutr Metab Cardiovasc Dis 20:618-625
4. Albani D, Polito L, Forloni G (2010) Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence. J Alzheimers Dis 19:11-26
5. Roy SK, Chen Q, Fu J, Shankar S, Srivastava RK (2011) Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS One 6(9):e25166
6. Zhou JH, Cheng HY, Yu ZQ, He DW, Pan Z, Yang DT (2011) Resveratrol induces apoptosis in pancreatic cancer cells. Chin Med J (Engl) 124(11):1695-1699
7. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
8. Winter J, Jung S, Keller S, Gregory RI, Diederich S (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11(3):228-234
9. Tili E, Michaille JJ, Alder H, Volinia S, Delmas D, Latruffe N, Croce CM (2010) Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. Biochem Pharmacol 80(12):2057-2065
10. Link A, Becker V, Goel A, Wex T, Malfertheiner P (2012) Feasibility of fecal MicroRNAs as novel biomarkers for pancreatic cancer. PLoS One 7(8):e42933
11. Pietenpol JA, Paradopoulos N, Markowitz S, Willson JK, Kinzler KW, Vogelstein B (1994) Paradoxival inhibition of solid tumor cell growth by bcl2. Cancer Res 54(14):3714-3717
12. Rückert F, Samm N, Lehner AK, Saeger HD, Grützmann R, Pilarsky C (2010) Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis. BMC Cancer 10:379
13. Dong J, Zhao YP, Zhou L, Zhang TP, Chen G (2011) Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells. Arch Med Res 42(1):8-14
14. Li J, Wang Y, Yu X, Chen H, Wu Y, Han X, Guo X, Zhang C, Chen Q, Chen J, Yang T (2009) Islet neogenesis-associated protein-related pentadeca peptide enhances the differentiation of islet-like clusters from human pancreatic duct cells. Peptides 30:2242-2249
15. Ma T, Zhu ZG, Ji YB et al (2004) Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2¢- deoxyuridine. World J Gastroenterol 10:172-176
16. Vermes I, Haanen C, Reutelingsperger C (2000) Flow cytometry of apoptotic cell death. J Immunol Methods 243:167-190
17. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275(5297):218-220
18. Mo W, Xu X, Xu L, Wang F, Ke A, Wang X, Guo C (2011) Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell. Pancreatology 11(6):601-609
19. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5(6):493-506
20. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10(2):111-122
21. Buscaglia LE, Li Y (2011) Apoptosis and the target genes of microRNA-21. Chin J Cancer 30(6):371-380
22. Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z (2010) MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 1352:255-264